Hrt Financial LP Spruce Biosciences, Inc. Transaction History

Hrt Financial LP

$15.7 Billion
Q4 2024

A detailed history of Hrt Financial LP transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 37,838 shares of SPRB stock, worth $15,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,838

Holding current value

$15,891

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$0.38 - $0.59 $14,378 - $22,324	37,838 New	37,838 $15,000
Q1 2023 May 12, 2023	BUY	$1.15 - $3.17 $15,340 - $42,287	13,340 New	13,340 $29,000

Others Institutions Holding SPRB

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

River Vest Venture Management LLC St. Louis, MO

2.94M
Shares

$1.23 Million
20.39% of portfolio
Carlyle Group Inc. Washington, DC

2.9M
Shares

$1.22 Million
1.19% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.61M
Shares

$1.1 Million
0.04% of portfolio
Abingworth LLP London, X0

1.79M
Shares

$752,857
0.65% of portfolio
Acadian Asset Management LLC Boston, MA

1.05M
Shares

$439,247
0.0% of portfolio

View Full List

About SPRUCE BIOSCIENCES, INC.

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.9M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

More about SPRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account